CORTESE, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 5.685
AS - Asia 3.061
EU - Europa 2.576
SA - Sud America 541
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 143
OC - Oceania 9
Totale 12.193
Nazione #
US - Stati Uniti d'America 5.480
SG - Singapore 976
CN - Cina 816
IE - Irlanda 581
IT - Italia 457
HK - Hong Kong 417
BR - Brasile 415
DE - Germania 371
RU - Federazione Russa 354
VN - Vietnam 324
FI - Finlandia 241
FR - Francia 178
BD - Bangladesh 126
IN - India 119
GB - Regno Unito 112
CA - Canada 101
ZA - Sudafrica 71
JP - Giappone 51
MX - Messico 47
AR - Argentina 44
ES - Italia 41
BE - Belgio 38
IQ - Iraq 37
NL - Olanda 30
AT - Austria 28
SE - Svezia 28
TR - Turchia 24
PL - Polonia 23
CO - Colombia 22
PK - Pakistan 20
CR - Costa Rica 18
CZ - Repubblica Ceca 18
ID - Indonesia 18
UA - Ucraina 17
MA - Marocco 16
LT - Lituania 15
UZ - Uzbekistan 14
EC - Ecuador 13
MY - Malesia 13
VE - Venezuela 13
PH - Filippine 12
KE - Kenya 11
PY - Paraguay 10
KR - Corea 9
PR - Porto Rico 9
SA - Arabia Saudita 9
AU - Australia 8
CL - Cile 8
ET - Etiopia 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
JO - Giordania 7
TN - Tunisia 7
BO - Bolivia 6
IR - Iran 6
KZ - Kazakistan 6
JM - Giamaica 5
PE - Perù 5
PT - Portogallo 5
SI - Slovenia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AO - Angola 4
DZ - Algeria 4
HN - Honduras 4
HR - Croazia 4
MU - Mauritius 4
NP - Nepal 4
AM - Armenia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
GP - Guadalupe 2
GR - Grecia 2
GY - Guiana 2
IS - Islanda 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 11.994
Città #
San Jose 607
Chandler 597
Singapore 584
Dublin 573
Ashburn 564
Hong Kong 403
Dallas 338
Council Bluffs 294
Beijing 224
Munich 219
Boardman 182
Los Angeles 170
Helsinki 160
Lauterbourg 118
Ho Chi Minh City 113
New York 111
Princeton 104
Lawrence 97
Wilmington 95
Hanoi 80
Redondo Beach 74
Medford 71
Rome 70
Santa Clara 67
Shanghai 67
Moscow 66
Nanjing 62
São Paulo 61
Milan 59
Johannesburg 56
Ann Arbor 50
Pavia 50
Tokyo 48
Turku 48
Buffalo 43
Jacksonville 43
Chicago 41
Atlanta 36
Orem 35
Brussels 34
Montreal 32
Seattle 32
Washington 30
Nuremberg 29
Brooklyn 27
Nanchang 27
Frankfurt am Main 25
Phoenix 24
Chennai 23
Columbus 23
Pune 23
The Dalles 23
Toronto 23
Fairfield 21
Jiaxing 21
Shenyang 21
London 20
Stockholm 20
Warsaw 20
Hebei 18
San Francisco 18
Changsha 17
Denver 17
Florence 17
Manchester 17
Woodbridge 17
Da Nang 16
Mexico City 16
Norwalk 16
San José 16
Baghdad 15
Charlotte 14
Houston 14
Palermo 14
Tashkent 14
Amsterdam 13
Boston 13
Tianjin 13
Cambridge 12
Guangzhou 12
Hangzhou 12
Mumbai 12
Naples 12
Falls Church 11
Rio de Janeiro 11
Turin 11
Vienna 11
Dhaka 10
Nairobi 10
New Delhi 10
North Bergen 10
Piscataway 10
Poplar 10
Brasília 9
Brno 9
Düsseldorf 9
Haiphong 9
Biên Hòa 8
Espoo 8
Hyderabad 8
Totale 7.697
Nome #
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 266
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 198
Contraction or sequence variant of an intergenic repeat-Alu element leads to inherited thyroid disease 194
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 181
AUTOIMMUNITY, ENVIRONMENT AND GENETICS IN INFLAMMATORY DISORDERS OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM 173
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 157
RFC1 expansions are a common cause of idiopathic sensory neuropathy 152
Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI 150
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 150
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 144
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 139
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 138
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion 138
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes 134
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 133
Diagnostics of dysimmune peripheral neuropathies 133
Diagnostics of anti-MAG antibody polyneuropathy 132
Air pollution as a contributor to the inflammatory activity of multiple sclerosis 129
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia 128
Ambient air pollution boosts MS activity through upregulation of adhesion molecules and chemokine receptors on circulating lymphocytes 123
Neurofascin-155 as a putative antigen in combined central and peripheral demyelination 121
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes 121
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial 119
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: Avoiding misdiagnosis of a treatable hereditary neuropathy 118
Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy 115
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy 114
Impact of environmental factors and physical activity on disability and quality of life in CIDP 114
Multiple memory-guided saccades: movement memory improves the accuracy of memory-guided saccades 113
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy 113
A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele 113
Monitoring late complications of zinc treatment in Wilson's disease. Reply to the letter: Copper deficiency in Wilson's disease: An avoidable complication of treatment: Monitoring Late Complications of Zinc Treatment in Wilson's Disease 110
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 109
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 109
Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15 108
Increased frequency of repeat expansion mutations across different populations 107
Author Correction: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia (Nature Genetics, (2019), 51, 4, (649-658), 10.1038/s41588-019-0372-4) 107
Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome 106
MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP 106
Theta-Burst Stimulation of the Cerebellum Interferes with Internal Representations of Sensory-Motor Information Related to Eye Movements in Humans 105
Variable echo time imaging for detecting the short T2* components of the sciatic nerve: a validation study 104
Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes (Nature Genetics, (2020), 52, 5, (473-481), 10.1038/s41588-020-0615-4) 104
A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement 104
Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination 103
Copper deficiency in Wilson's disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment 103
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 103
An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy 103
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 102
Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic 101
Late onset oculopharyngeal muscular dystrophy with prominent neurogenic features and short GCG trinucleotide expansion 101
Corrigendum to “MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP” [Journal of the Neurological Sciences Volume 400, 15 May 2019, Pages 15–20](S0022510X19301145)(10.1016/j.jns.2019.03.001) 100
Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropathy 100
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study 100
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 99
Theta burst stimulation of the cerebellum impairs motor learning in humans. 99
Neurological disorders caused by novel non-coding repeat expansions: clinical features and differential diagnosis 98
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 98
Progressive post infectious neurological syndromes with a poor outcome: Long term follow-up and neurofilament light chain quantification 96
A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry 96
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial 95
Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease Spectrum 94
Tissue-specific TCF4 triplet repeat instability revealed by optical genome mapping 94
Laryngeal and phrenic nerve involvement in a patient with hereditary neuropathy with liability to pressure palsies (HNPP) 94
Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis 93
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease 93
Botulinum toxin is effective in the management of neurogenic dysphagia. clinical-electrophysiological findings and tips on safety in different neurological disorders 92
A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families 92
Author response 92
Quantitative MRI Assessment Using Variable Echo Time Imaging of Peripheral Nerve Injury in ATTRv Amyloidosis Patients 91
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy (PLoS ONE (2019) 14: 2 (e0212647) DOI: 10.1371/journal.pone.0212647) 91
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects 89
Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient 87
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. 86
Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorder 85
Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 85
Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre 84
Novel CLN3 mutation causing autophagic vacuolar myopathy 84
CLINICAL FEATURES AND SEROLOGICAL PROFILE OF COMBINED CENTRAL AND PERIPHERAL DEMYELINATION 83
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 82
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 82
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease 81
AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons 80
Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathy 78
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A 77
Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease 74
Varicella zoster virus-associated polyradiculoneuritis 74
Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease 74
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy 74
RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia 74
Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges 73
Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials 72
Correlation of clinical and molecular features in spinal bulbar muscular atrophy 72
RFC1 expansions can mimic hereditary sensory neuropathy with cough and Sjögren syndrome 72
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database 70
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 70
Heterozygous APTX mutation associated with atypical multiple system atrophy-like phenotype: A case report 69
Severe cognitive impairment in a patient with CMT2A 69
CANVAS: case report on a novel repeat expansion disorder with late-onset ataxia 69
Optical Genome Mapping Enables Detection and Accurate Sizing of RFC1 Repeat Expansions 68
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study 68
Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia 68
Totale 10.528
Categoria #
all - tutte 57.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022475 0 0 0 14 14 35 9 37 40 4 68 254
2022/20231.553 150 132 24 163 105 166 8 75 658 14 36 22
2023/2024847 87 98 32 54 56 195 25 68 5 37 53 137
2024/20252.386 137 140 29 94 84 161 159 148 543 148 256 487
2025/20265.030 376 281 492 526 685 194 1.018 193 519 306 311 129
2026/20271.322 276 275 297 474 0 0 0 0 0 0 0 0
Totale 12.193